top
Search terms
Results 21 - 29 of 29 - ordered by :
Pages: 1 2 3
Ehjcvp

In this issue of the journal, Dr Vries and co-workers report data from a study that aimed to explore the level of agreement between windows for different platelet function tests (PFTs) used to ...

European Heart Journal - Cardiovascular Pharmacotherapy, Editorials, Stefan Agewall

Date : 01/01/2017 Item size : 132260 bytes
Ehjcvp

Abstract Aims To determine whether risk factor changes over 6 years were associated with the incidence of atrial fibrillation (AF) among middle-aged men in the Malmö Preventive Project (MPP) ...

European Heart Journal - Cardiovascular Pharmacotherapy, ORIGINAL ARTICLE, Linda S.B. Johnson, Tord Juhlin, Gunnar Engström, Peter M. Nilsson

Date : 01/04/2016
Ehjcvp

A recently published postmarketing study has shown that dabigatran causes a significantly higher risk of extracranial bleeding than VKAs in clinical practice.3 It was also found that NVAF patients ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIALS, Herbert J.A. Rolden, Janneke P.C. Grutters, Gert Jan van der Wilt, Angela H.E.M. Maas

Date : 01/07/2015
Ehjcvp

While rhythm control is recommended in patients with AF-related symptoms despite rate control, this therapeutic concept has been less often applied since the publication of AFFIRM.1,2 If physicians ...

European Heart Journal - Cardiovascular Pharmacotherapy, INVITED EDITORIAL, Bernhard M. Kaess, Joachim R. Ehrlich

Date : 01/04/2016
Ehjcvp

Methods and results In this observational study, 5426 Chinese AF patients (77.7 ± 10.7 years, female: 53.1%) with a CHA2DS2-VASc score of 1 were included in the final analysis: of which, 3832 ...

European Heart Journal - Cardiovascular Pharmacotherapy, ORIGINAL ARTICLE, Pak-Hei Chan, Wen-Hua Li, Jo-Jo Hai, Koon-Ho Chan, Hung-Fat Tse, Bernard Man-Yung Cheung, Esther W. Chan, Ian C.K. Wong, ...

Date : 01/10/2015
Ehjcvp

Abstract Aims Non-steroidal anti-inflammatory drugs (NSAIDs) are associated with increased risk of cardiovascular disease. Non-steroidal anti-inflammatory drugs (NSAIDs)Myocardial infarctionAtrial ...

European Heart Journal - Cardiovascular Pharmacotherapy, ORIGINAL ARTICLES, Anne-Marie Schjerning Olsen, Emil L. Fosbøl, Jannik Pallisgaard, Jesper Lindhardsen, Morten Lock Hansen, Lars Køber, ...

Date : 01/04/2015
Ehjcvp

Anti-coagulantAnti-plateletAtrial fibrillationBleeding,HaemorrhageNovel oral anti-coagulantStrokeVitamin K antagonistIntroduction In patients with atrial fibrillation (AF), Vitamin K antagonists ...

European Heart Journal - Cardiovascular Pharmacotherapy, ORIGINAL ARTICLE, Ariel Dogliotti, Robert P. Giugliano

Date : 01/01/2015
Ehjcvp

Renin angiotensin system inhibitor and β-blocker combination therapy After treatment optimization, 78.5% patients were treated with combination therapy including both a RASI and a β-blocker; ...

European Heart Journal - Cardiovascular Pharmacotherapy, ORIGINAL ARTICLE, Jonathan De Blois, Morten Wang Fagerland, Morten Grundtvig, Anne Grete Semb, Lars Gullestad, Arne Westheim, Torstein Hole, ...

Date : 01/01/2015
Ehjcvp

Using a Cox proportional hazard model adjusting for baseline characteristics, use of apixaban [hazard ratio (HR) 0.70, 95% confidence interval (CI) 0.610.80, P0.001] and dabigatran (HR 0.74, 95% CI ...

European Heart Journal - Cardiovascular Pharmacotherapy, Original Article, Sigrun Halvorsen, Waleed Ghanima, Ingunn Fride Tvete, Cecilie Hoxmark, PÃ¥l Falck, Oddvar Solli, Christian Jonasson

Date : 27/09/2016